您当前的位置:
首页 >
文章列表页 >
Principal Component Analysis of Gene Expression of Baicalin,Jasminoidin and Their Combination in Experimental Stroke
更新时间:2021-11-17
    • Principal Component Analysis of Gene Expression of Baicalin,Jasminoidin and Their Combination in Experimental Stroke

    • Journal of Traditional Chinese Medicine   Vol. 51, Issue 2, Pages: 164-167(2010)
    • DOI:10.13288/j.11-2166/r.2010.02.039    

      CLC: R285
    • Published:2010

    移动端阅览

  • JING Zhiwei1, ZHOU Caixiu1, WANG Zhong1, et al. Principal Component Analysis of Gene Expression of Baicalin,Jasminoidin and Their Combination in Experimental Stroke[J]. Journal of Traditional Chinese Medicine2010, 51(2): 164-167. DOI: 10.13288/j.11-2166/r.2010.02.039.

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >
查看原文

0

Views

647

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Exploring the Mechanism of Action of Qizhu Kang'ai Formula (芪术抗癌方) for the Treatment of Colorectal Cancer based on Network Pharmacology and Experimental Validation
Effect of Tongxinluo Superfine Powder on Microvessels in Cerebral Ischemia Rats
Effect of Naoluo Xintong Liquid on the Coagulation and Fibrinolytic System in Rats with Focal Cerebral Ischemia
The Effect of Qingre Huoxue Fang( 清热活血方) on Migration and Adhesion of Fibroblast-like Synoviocytes of Rheumatoid Arthritis Induced by Tumor Necrosis Factorα
Effect of Ligustrazine on the Adhesion of PG-BE1 Stem Like Cells in the Pulmonary Giant Cell Carcinoma of Human with High Metastatic Lung Cancer

Related Author

TANG Decai
YIN Gang
YIN Qihang
WANG Xu
WAN Linlu
ZHU Shijiao
ZHAO Fan
LIANG Yan

Related Institution

School of Pharmacy, Nanjing University of Chinese Medicine
School of Chinese Medicine, Nanjing University of Chinese Medicine
Yiling Hospital Affiliated to Hebei Medical University
Key Laboratory of Hebei Province for Vessel Diseases
Shijiazhuang Yiling Pharmaceutical Company
0